EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Antimicrobial Peptides towards Clinical Application—A Long History to Be Concluded

Laura Cresti, Giovanni Cappello, Alessandro Pini

International Journal of Molecular Sciences · 29.04.2024 · 25 (9) · 4870

DOI: 10.3390/ijms25094870 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 29.04.2024. Verfasst von Laura Cresti und 2 weiteren Autor:innen. Beteiligte Einrichtung: Medical Biotechnology Department, University of Siena, Via A Moro 2, 53100 Siena, Italy. Hauptthemen laut MEDLINE: Antimicrobial Peptides. Die Arbeit wurde bisher 128-mal zitiert (Crossref) und nennt 143 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Italian NRRP, Tuscany Health Ecosystem SPOKE 7, HORIZON-MSCA-2021-DN-01, Regione Toscana, Italy, CALL COVID-19.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Antimicrobial peptides (AMPs) are molecules with an amphipathic structure that enables them to interact with bacterial membranes. This interaction can lead to membrane crossing and disruption with pore formation, culminating in cell death. They are produced naturally in various organisms, including humans, animals, plants and microorganisms. In higher animals, they are part of the innate immune system, where they counteract infection by bacteria, fungi, viruses and parasites. AMPs can also be designed de novo by bioinformatic approaches or selected from combinatorial libraries, and then produced by chemical or recombinant procedures. Since their discovery, AMPs have aroused interest as potential antibiotics, although few have reached the market due to stability limits or toxicity. Here, we describe the development phase and a number of clinical trials of antimicrobial peptides. We also provide an update on AMPs in the pharmaceutical industry and an overall view of their therapeutic market. Modifications to peptide structures to improve stability in vivo and bioavailability are also described.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antimicrobial PeptidesHumansAnimalsClinical Trials as TopicAntimicrobial Cationic Peptides

Stichwörter der Autor:innen

antimicrobial peptidesantimicrobial resistancechemical modificationsclinical developmentpreclinical developmenttoxicity

Substanzen

Antimicrobial PeptidesAntimicrobial Cationic Peptides

Autor:innen und Institutionen

  • Medical Biotechnology Department, University of Siena, Via A Moro 2, 53100 Siena, Italy.
  • SetLance srl, Via Fiorentina 1, 53100 Siena, Italy.
  • Laboratory of Clinical Pathology, Santa Maria alle Scotte University Hospital, 53100 Siena, Italy.

Förderung

  • Italian NRRP, Tuscany Health Ecosystem SPOKE 7
  • HORIZON-MSCA-2021-DN-01
  • Regione Toscana, Italy, CALL COVID-19
  • Italian PRIN 2022

Zitieren

APA

Cresti, L., Cappello, G., & Pini, A. (2024). Antimicrobial Peptides towards Clinical Application—A Long History to Be Concluded. International Journal of Molecular Sciences, 25(9), 4870. https://doi.org/10.3390/ijms25094870

Vancouver

Cresti L, Cappello G, Pini A. Antimicrobial Peptides towards Clinical Application—A Long History to Be Concluded. International Journal of Molecular Sciences. 2024;25(9):4870. doi:10.3390/ijms25094870

BibTeX
@article{Cresti2024,
  author = {Cresti, Laura and Cappello, Giovanni and Pini, Alessandro},
  title = {Antimicrobial Peptides towards Clinical Application—A Long History to Be Concluded},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  volume = {25},
  number = {9},
  pages = {4870},
  doi = {10.3390/ijms25094870}
}
Kostenlos starten →